 | • レポートコード：MRC2312MG13082 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、65ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の間葉系幹細胞（MSC）療法市場規模と予測を収録しています。・世界の間葉系幹細胞（MSC）療法市場：売上、2018年-2023年、2024年-2029年 ・世界の間葉系幹細胞（MSC）療法市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の間葉系幹細胞（MSC）療法市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「静脈内（IV）」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 間葉系幹細胞（MSC）療法のグローバル主要企業は、TotiCell、 Celltex、 InGeneron、 Stempeutics Bangalore、 PuREC、 Corestem、 Sartorius、 StemcellX、 Cynata、 Amniotic、 Nuwacellなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、間葉系幹細胞（MSC）療法のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の間葉系幹細胞（MSC）療法市場：タイプ別、2018年-2023年、2024年-2029年 世界の間葉系幹細胞（MSC）療法市場：タイプ別市場シェア、2022年 ・静脈内（IV）、経鼻（IN）、関節内（IA）、その他 世界の間葉系幹細胞（MSC）療法市場：用途別、2018年-2023年、2024年-2029年 世界の間葉系幹細胞（MSC）療法市場：用途別市場シェア、2022年 ・病院、診療所、研究所、その他 世界の間葉系幹細胞（MSC）療法市場：地域・国別、2018年-2023年、2024年-2029年 世界の間葉系幹細胞（MSC）療法市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における間葉系幹細胞（MSC）療法のグローバル売上、2018年-2023年 ・主要企業における間葉系幹細胞（MSC）療法のグローバル売上シェア、2022年 ・主要企業における間葉系幹細胞（MSC）療法のグローバル販売量、2018年-2023年 ・主要企業における間葉系幹細胞（MSC）療法のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 TotiCell、 Celltex、 InGeneron、 Stempeutics Bangalore、 PuREC、 Corestem、 Sartorius、 StemcellX、 Cynata、 Amniotic、 Nuwacell ************************************************************* ・調査・分析レポートの概要 間葉系幹細胞（MSC）療法市場の定義 市場セグメント 世界の間葉系幹細胞（MSC）療法市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の間葉系幹細胞（MSC）療法市場規模 世界の間葉系幹細胞（MSC）療法市場規模：2022年 VS 2029年 世界の間葉系幹細胞（MSC）療法市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの間葉系幹細胞（MSC）療法の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の間葉系幹細胞（MSC）療法製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：静脈内（IV）、経鼻（IN）、関節内（IA）、その他 間葉系幹細胞（MSC）療法のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、研究所、その他 間葉系幹細胞（MSC）療法の用途別グローバル売上・予測 ・地域別市場分析 地域別間葉系幹細胞（MSC）療法市場規模 2022年と2029年 地域別間葉系幹細胞（MSC）療法売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） TotiCell、 Celltex、 InGeneron、 Stempeutics Bangalore、 PuREC、 Corestem、 Sartorius、 StemcellX、 Cynata、 Amniotic、 Nuwacell ... |
This research report provides a comprehensive analysis of the Mesenchymal Stem Cell (MSC) Therapy market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Mesenchymal Stem Cell (MSC) Therapy market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Mesenchymal Stem Cell (MSC) Therapy, challenges faced by the industry, and potential opportunities for market players.
The global Mesenchymal Stem Cell (MSC) Therapy market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Mesenchymal Stem Cell (MSC) Therapy market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Mesenchymal Stem Cell (MSC) Therapy market. Additionally, the growing consumer demand present avenues for market expansion.
The global Mesenchymal Stem Cell (MSC) Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Mesenchymal Stem Cell (MSC) Therapy market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Mesenchymal Stem Cell (MSC) Therapy market.
Market Overview: The report provides a comprehensive overview of the Mesenchymal Stem Cell (MSC) Therapy market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Intravenous (IV), Intranasal (IN)), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Mesenchymal Stem Cell (MSC) Therapy market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Mesenchymal Stem Cell (MSC) Therapy market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Mesenchymal Stem Cell (MSC) Therapy market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Mesenchymal Stem Cell (MSC) Therapy market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Mesenchymal Stem Cell (MSC) Therapy market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Mesenchymal Stem Cell (MSC) Therapy market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Mesenchymal Stem Cell (MSC) Therapy, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Mesenchymal Stem Cell (MSC) Therapy market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Mesenchymal Stem Cell (MSC) Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Intravenous (IV)
Intranasal (IN)
Intraarticular (IA)
Others
Market segment by Application
Hospital
Clinic
Research Institute
Others
Global Mesenchymal Stem Cell (MSC) Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
TotiCell
Celltex
InGeneron
Stempeutics Bangalore
PuREC
Corestem
Sartorius
StemcellX
Cynata
Amniotic
Nuwacell
Outline of Major Chapters:
Chapter 1: Introduces the definition of Mesenchymal Stem Cell (MSC) Therapy, market overview.
Chapter 2: Global Mesenchymal Stem Cell (MSC) Therapy market size in revenue.
Chapter 3: Detailed analysis of Mesenchymal Stem Cell (MSC) Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mesenchymal Stem Cell (MSC) Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Mesenchymal Stem Cell (MSC) Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mesenchymal Stem Cell (MSC) Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mesenchymal Stem Cell (MSC) Therapy Overall Market Size
2.1 Global Mesenchymal Stem Cell (MSC) Therapy Market Size: 2022 VS 2029
2.2 Global Mesenchymal Stem Cell (MSC) Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Mesenchymal Stem Cell (MSC) Therapy Players in Global Market
3.2 Top Global Mesenchymal Stem Cell (MSC) Therapy Companies Ranked by Revenue
3.3 Global Mesenchymal Stem Cell (MSC) Therapy Revenue by Companies
3.4 Top 3 and Top 5 Mesenchymal Stem Cell (MSC) Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Mesenchymal Stem Cell (MSC) Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mesenchymal Stem Cell (MSC) Therapy Players in Global Market
3.6.1 List of Global Tier 1 Mesenchymal Stem Cell (MSC) Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Mesenchymal Stem Cell (MSC) Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Mesenchymal Stem Cell (MSC) Therapy Market Size Markets, 2022 & 2029
4.1.2 Intravenous (IV)
4.1.3 Intranasal (IN)
4.1.4 Intraarticular (IA)
4.1.5 Others
4.2 By Type – Global Mesenchymal Stem Cell (MSC) Therapy Revenue & Forecasts
4.2.1 By Type – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2023
4.2.2 By Type – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, 2024-2029
4.2.3 By Type – Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Mesenchymal Stem Cell (MSC) Therapy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Research Institute
5.1.5 Others
5.2 By Application – Global Mesenchymal Stem Cell (MSC) Therapy Revenue & Forecasts
5.2.1 By Application – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2023
5.2.2 By Application – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, 2024-2029
5.2.3 By Application – Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Mesenchymal Stem Cell (MSC) Therapy Market Size, 2022 & 2029
6.2 By Region – Global Mesenchymal Stem Cell (MSC) Therapy Revenue & Forecasts
6.2.1 By Region – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2023
6.2.2 By Region – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, 2024-2029
6.2.3 By Region – Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2029
6.3.2 US Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.3.3 Canada Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.3.4 Mexico Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2029
6.4.2 Germany Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.4.3 France Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.4.4 U.K. Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.4.5 Italy Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.4.6 Russia Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.4.8 Benelux Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2029
6.5.2 China Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.5.3 Japan Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.5.4 South Korea Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.5.6 India Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2029
6.6.2 Brazil Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.6.3 Argentina Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2029
6.7.2 Turkey Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.7.3 Israel Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.7.5 UAE Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
7 Mesenchymal Stem Cell (MSC) Therapy Companies Profiles
7.1 TotiCell
7.1.1 TotiCell Company Summary
7.1.2 TotiCell Business Overview
7.1.3 TotiCell Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.1.4 TotiCell Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.1.5 TotiCell Key News & Latest Developments
7.2 Celltex
7.2.1 Celltex Company Summary
7.2.2 Celltex Business Overview
7.2.3 Celltex Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.2.4 Celltex Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.2.5 Celltex Key News & Latest Developments
7.3 InGeneron
7.3.1 InGeneron Company Summary
7.3.2 InGeneron Business Overview
7.3.3 InGeneron Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.3.4 InGeneron Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.3.5 InGeneron Key News & Latest Developments
7.4 Stempeutics Bangalore
7.4.1 Stempeutics Bangalore Company Summary
7.4.2 Stempeutics Bangalore Business Overview
7.4.3 Stempeutics Bangalore Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.4.4 Stempeutics Bangalore Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.4.5 Stempeutics Bangalore Key News & Latest Developments
7.5 PuREC
7.5.1 PuREC Company Summary
7.5.2 PuREC Business Overview
7.5.3 PuREC Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.5.4 PuREC Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.5.5 PuREC Key News & Latest Developments
7.6 Corestem
7.6.1 Corestem Company Summary
7.6.2 Corestem Business Overview
7.6.3 Corestem Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.6.4 Corestem Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.6.5 Corestem Key News & Latest Developments
7.7 Sartorius
7.7.1 Sartorius Company Summary
7.7.2 Sartorius Business Overview
7.7.3 Sartorius Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.7.4 Sartorius Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.7.5 Sartorius Key News & Latest Developments
7.8 StemcellX
7.8.1 StemcellX Company Summary
7.8.2 StemcellX Business Overview
7.8.3 StemcellX Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.8.4 StemcellX Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.8.5 StemcellX Key News & Latest Developments
7.9 Cynata
7.9.1 Cynata Company Summary
7.9.2 Cynata Business Overview
7.9.3 Cynata Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.9.4 Cynata Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.9.5 Cynata Key News & Latest Developments
7.10 Amniotic
7.10.1 Amniotic Company Summary
7.10.2 Amniotic Business Overview
7.10.3 Amniotic Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.10.4 Amniotic Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.10.5 Amniotic Key News & Latest Developments
7.11 Nuwacell
7.11.1 Nuwacell Company Summary
7.11.2 Nuwacell Business Overview
7.11.3 Nuwacell Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.11.4 Nuwacell Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.11.5 Nuwacell Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer